false
0001735948
A6
0001735948
2024-02-15
2024-02-15
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
February 15, 2024
GREENBROOK TMS INC.
(Exact name of registrant as specified in its
charter)
Ontario |
|
001-40199 |
|
98-1512724 |
(State or Other Jurisdiction
of Incorporation) |
|
(Commission
File No.) |
|
(IRS Employee
Identification No.) |
890 Yonge Street, 7th Floor
Toronto, Ontario Canada
M4W 3P4
(Address of Principal Executive Offices)
(866) 928-6076
(Registrant’s telephone number, including
area code)
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class |
|
Trading
Symbol(s) |
|
Name of Each Exchange
on Which Registered |
Common Shares, without par value |
|
GBNH |
|
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company x
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act.
Item 1.01 | Entry into a Material Definitive Agreement. |
On
February 15, 2024, Greenbrook TMS Inc. (the “Company”) entered into the twenty-fifth amendment (the “Amendment”)
to the Company’s credit agreement, dated as of July 14, 2022 (as previously amended and as amended by the Amendment, the “Credit
Agreement”), by and among the Company, certain of its subsidiaries party thereto as guarantors, Madryn Fund Administration,
LLC, as administrative agent (“Madryn”) and the lenders party thereto. Pursuant to the Amendment, the Company borrowed
US$2,538,071 in senior secured term loans (the “New Loan”), the proceeds of which are expected to be used by the Company
for general corporate and working capital purposes.
After
giving effect to the Amendment and the borrowing of the New Loan, the aggregate principal amount outstanding under the Credit Agreement
is approximately US$87 million (collectively, the “Loans”). The Loans accrue interest at a rate per annum equal to
9.0% plus the 3-month term Secured Overnight Financing Rate (subject to a floor of 1.5%) plus 0.10%. The Loans mature over 63 months and
provide for four years of interest-only payments. The outstanding principal balance is due in five equal quarterly installments beginning
on September 30, 2026. The Company has granted a lien on, and security interest in, all assets of the Company as security for the
performance and prompt payment of the obligations of the Loan Parties under the Credit Agreement.
The
Amendment also extends the period during which the Company’s minimum liquidity covenant is reduced from US$3,000,000 to US$300,000
to March 15, 2024.
The
terms of the Credit Agreement require the Company to satisfy various affirmative and negative covenants and to meet certain financial
tests, including but not limited to, financial covenants that require the Company to (i) generate consolidated revenues for any 4
consecutive quarter period, measured quarterly for the 4 consecutive quarter period prior to the end of each quarter, in amounts that
represent a specified percentage of the Company’s projected consolidated revenues for such measurement periods, assuming modest
growth over time; and (ii) maintain minimum liquidity of $300,000 until March 15, 2024 and $3.0 million thereafter, tested on
a daily basis. In addition, the Credit Agreement contains affirmative and negative covenants that limit, among other things, the Company’s
ability to incur additional indebtedness, incur certain liens, declare certain dividends and engage in certain types of transactions.
The Credit Agreement also contains affirmative covenants that require the Company to deliver, within 90 days of each fiscal year end,
audited financial statements for such fiscal year, accompanied by a report and opinion of an independent certified public accountant which
is not subject to any “going concern” or like qualification or exception or any qualification or exception as to the scope
of such audit.
The
Credit Agreement contains a number of events of default including, without limitation, (a) non-payment of principal when due; (b) failure
to pay interest, fees or repayment premiums within 3 business days after the same becomes due; (c) failure to pay other amounts under
the Credit Agreement and Investment Documents (as defined in the Credit Agreement) within 5 business days after the same becomes due;
(d) failure to comply with the covenants in the Credit Agreement (subject to specified grace periods); (e) cross-default to
indebtedness in an aggregate principal amount in excess of $1,000,000; (f) the initiation of insolvency proceedings; (g) the
Company or any of its Subsidiaries (as defined in the Credit Agreement) becomes unable to, admits in writing its inability to, or fails
to pay, its debts as due; (h) the occurrence of specified events which may have a Material Adverse Effect (as defined in the Credit
Agreement), as further described in Section 9.01(l) of the Credit Agreement; and (i) entry into a final judgment against
the Company (or any subsidiary) for the payment of money in an aggregate amount exceeding $1,000,000 or any non-monetary final judgment
that could reasonably be expected to have a Material Adverse Effect (as defined in the Credit Agreement) and, in either case, enforcement
proceedings are commenced by a creditor or there is a period of 30 consecutive days during which a stay of enforcement is not in effect.
Additionally,
affiliates of Madryn are collectively the Company’s largest shareholder. As reported in Madryn Asset Management, LP’s amended
Schedule 13D filed with the Securities and Exchange Commission (the “Commission”) on October 24, 2023, affiliates
of Madryn beneficially own 45% of the Company’s common shares (the “Common Shares”) upon full conversion of the
convertible instruments held under both the terms of the Credit Agreement and the note purchase agreement entered into by, among others,
the Company and affiliates of Madryn on August 15, 2023.
The
foregoing is not a complete discussion of the Credit Agreement and is qualified in its entirety by reference to the full text of the Credit
Agreement. A copy of the seventh amended credit agreement, dated as of March 24, 2023 (the “Seventh Amended Credit Agreement”)
was filed as Exhibit 4.7 to the Company’s annual report on Form 20-F for the year ended December 31, 2022 and filed
with the Commission on April 18, 2023. Defined terms used herein that are not defined are as defined in the Seventh Amended Credit
Agreement. All such defined terms retain the same definition as in the current Credit Agreement, which will be filed as an exhibit to
the Company’s annual report on Form 10-K for the year ended December 31, 2023. Pursuant to Item 601(b)(10)(iv) of
Regulation S-K, the Company intends to redact from the filed copy of the Credit Agreement certain information that is both (i) not
material and (ii) is the type of information that the Company treats as private or confidential.
Certain
statements contained in this Current Report on Form 8-K, including statements relating to the New Loan and the expected use of proceeds
therefrom, may constitute “forward-looking information” within the meaning of applicable securities laws in Canada and “forward-looking
statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995 (collectively, “forward-looking
information”). Forward-looking information may relate to the Company’s future financial and liquidity outlook and anticipated
events or results and may include information regarding the Company’s business, financial position, results of operations, business
strategy, growth plans and strategies, technological development and implementation, budgets, operations, financial results, taxes, dividend
policy, plans and objectives. Particularly, information regarding the New Loan and the expected use of proceeds therefrom, may be forward-looking
information. In some cases, forward-looking information can be identified by the use of forward-looking terminology such as “plans”,
“targets”, “expects” or “does not expect”, “is expected”, “an opportunity exists”,
“budget”, “scheduled”, “estimates”, “outlook”, “forecasts”, “projection”,
“prospects”, “strategy”, “intends”, “anticipates”, “does not anticipate”,
“believes”, or variations of such words and phrases or statements that certain actions, events or results “may”,
“should”, “could”, “would”, “might”, “will”, “will be taken”,
“occur” or “be achieved”. In addition, any statements that refer to expectations, intentions, projections or other
characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking information
are not facts but instead represent management’s expectations, estimates and projections regarding future events or circumstances.
Forward-looking
information is necessarily based on a number of opinions, assumptions and estimates that, while considered reasonable by the Company as
of the date of this Current Report on Form 8-K, are subject to known and unknown risks, uncertainties, assumptions and other factors
that may cause the actual results, level of activity, performance or achievements or future events or developments to differ materially
from those expressed or implied by the forward-looking statements, including, without limitation: macroeconomic factors such as inflation
and recessionary conditions, substantial doubt regarding the Company’s ability to continue as a going concern due to recurring losses
from operations; inability to increase cash flow and/or raise sufficient capital to support the Company’s operating activities and
fund its cash obligations, repay indebtedness and satisfy the Company’s working capital needs and debt obligations; prolonged decline
in the price of the Company’s Common Shares reducing the Company’s ability to raise capital; inability to satisfy debt covenants
under the Credit Agreement and the potential acceleration of indebtedness; risks related to the resolution of the Company’s ongoing
litigation with Benjamin Klein and compliance with the terms of their settlement agreement; risks related to the ability to continue to
negotiate amendments to the Credit Agreement to prevent a default; risks relating to the Company’s ability to deliver and execute
on the previously-announced restructuring plan (the “Restructuring Plan”) and the possible failure to complete the
Restructuring Plan on terms acceptable to the Company or its suppliers (including Neuronetics, Inc.), or at all; risks relating to
maintaining an active, liquid and orderly trading market for Common Shares as a result of the Company’s recent delisting notification
and potential inability to regain compliance with the Nasdaq Stock Market’s listing rules; risks relating to the Company’s
ability to realize expected cost-savings and other anticipated benefits from the Restructuring Plan; risks related to the Company’s
negative cash flows, liquidity and its ability to secure additional financing; increases in indebtedness levels causing a reduction in
financial flexibility; inability to achieve or sustain profitability in the future; inability to secure additional financing to fund losses
from operations and satisfy the Company’s debt obligations; risks relating to strategic alternatives, including restructuring or
refinancing of the Company’s debt, seeking additional debt or equity capital, reducing or delaying the Company’s business
activities and strategic initiatives, or selling assets, other strategic transactions and/or other measures, including obtaining bankruptcy
protection, and the terms, value and timing of any transaction resulting from that process; claims made by or against the Company, which
may be resolved unfavorably to us; risks relating to the Company’s dependence on Neuronetics, Inc. as its exclusive supplier
of TMS devices. Additional risks and uncertainties are discussed in the Company’s materials filed with the Canadian securities regulatory
authorities and the Commission from time to time, available at www.sedarplus.ca and www.sec.gov, respectively. These factors are not intended
to represent a complete list of the factors that could affect the Company; however, these factors should be considered carefully. There
can be no assurance that such estimates and assumptions will prove to be correct. The forward-looking statements contained in this Current
Report on Form 8-K are made as of the date of this report, and the Company expressly disclaims any obligation to update or alter
statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information,
future events or otherwise, except as required by law.
Item 2.03 | Creation of a Direct Financial Obligation or an Obligation
under an Off-Balance Sheet Arrangement of a Registrant. |
The
information provided in Item 1.01 is incorporated by reference herein.
Item 7.01 | Regulation FD Disclosure. |
On
February 15, 2024, the Company issued a press release announcing that it had entered into the Amendment to the Credit Agreement
and the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
The
information contained in this Current Report on Form 8-K under Item 7.01, including the attached Exhibit 99.1, is being furnished
pursuant to Item 7.01 of Form 8-K and shall not be deemed to be “filed” for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. The
information contained in this Current Report on Form 8-K under Item 7.01, shall not be incorporated by reference into any filing
under the Securities Act of 1933, as amended, or any filing under the Exchange Act, whether made before or after the date hereof, except
as shall be expressly set forth by specific reference in such a filing.
Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibits.
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Date: February 15, 2024
|
|
Greenbrook TMS Inc. |
|
|
|
|
|
|
By: |
/s/
Bill Leonard |
|
|
Name: |
Bill Leonard |
|
|
Title: |
President & Chief Executive Officer |
Exhibit 99.1
GREENBROOK TMS RAISES US$2.5 MILLION IN DEBT
FINANCING
February 15,
2024 – Toronto, ON – Greenbrook TMS Inc. (NASDAQ: GBNH) (“Greenbrook” or the “Company”)
today announced that it has entered into the twenty-fifth amendment (the “Amendment”) to the Company’s credit
facility (the “Credit Facility”) with affiliates of Madryn Asset Management, LP (“Madryn”). As
part of the Amendment, the Company secured an additional US$2,538,071 in senior secured term loans from Madryn under the Credit Facility
(the “New Loan”). After giving effect to the New Loan, the Company has an aggregate amount of approximately US$87
million outstanding under the Credit Facility.
The proceeds of the New Loan are expected to be
used by the Company for general corporate and working capital purposes. The Company is also currently considering additional near-term
financing options to address its future liquidity needs.
The Amendment also extends the period during which
the Company’s minimum liquidity covenant is reduced from US$3,000,000 to US$300,000 to March 15, 2024.
MI 61-101 Disclosure
Madryn is an insider of the Company. Accordingly,
the foregoing transactions are considered “related party transactions” for purposes of Multilateral Instrument 61-101 –
Protection of Minority Security Holders in Special Transactions (“MI 61-101”). The foregoing transactions were
reviewed and unanimously approved by the independent members of the board of directors of the Company. The New Loan, which is not convertible
into securities of Greenbrook, is exempt from the minority approval requirements under section 5.7(1)(f) of MI 61-101 because the
New Loan is on reasonable commercial terms that are not less advantageous to the Company than alternative financings that may have been
available at the time that terms were agreed with Madryn. Furthermore, a formal valuation is not required under MI 61-101 as the foregoing
transactions are not the type of related party transaction that requires a formal valuation.
About Greenbrook TMS Inc.
Operating through 130 Company-operated treatment
centers, Greenbrook is a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy and Spravato® (esketamine
nasal spray), FDA-cleared, non-invasive therapies for the treatment of Major Depressive Disorder (“MDD”) and other
mental health disorders, in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known
to be directly associated with mood regulation. Spravato® is offered to treat adults with treatment-resistant depression and depressive
symptoms in adults with MDD with suicidal thoughts or actions. Greenbrook has provided more than 1.3 million treatments to over 40,000
patients struggling with depression.
For further information please contact:
Glen Akselrod
Investor Relations
Greenbrook TMS Inc.
Contact Information:
investorrelations@greenbrooktms.com
1-855-797-4867
Cautionary Note Regarding Forward-Looking Information
Certain statements contained in this press release,
including statements relating to the New Loan and the expected use of proceeds therefrom, may constitute “forward-looking information”
within the meaning of applicable securities laws in Canada and “forward-looking statements” within the meaning of the United
States Private Securities Litigation Reform Act of 1995 (collectively, “forward-looking information”). Forward-looking
information may relate to the Company’s future financial and liquidity outlook and anticipated events or results and may include
information regarding the Company’s business, financial position, results of operations, business strategy, growth plans and strategies,
technological development and implementation, budgets, operations, financial results, taxes, dividend policy, plans and objectives. Particularly,
information regarding the New Loan and the expected use of proceeds therefrom may be forward-looking information. In some cases, forward-looking
information can be identified by the use of forward-looking terminology such as “plans”, “targets”, “expects”
or “does not expect”, “is expected”, “an opportunity exists”, “budget”, “scheduled”,
“estimates”, “outlook”, “forecasts”, “projection”, “prospects”, “strategy”,
“intends”, “anticipates”, “does not anticipate”, “believes”, or variations of such words
and phrases or statements that certain actions, events or results “may”, “should”, “could”, “would”,
“might”, “will”, “will be taken”, “occur” or “be achieved”. In addition, any
statements that refer to expectations, intentions, projections or other characterizations of future events or circumstances contain forward-looking
information. Statements containing forward-looking information are not facts but instead represent management’s expectations, estimates
and projections regarding future events or circumstances.
Forward-looking information is necessarily based
on a number of opinions, assumptions and estimates that, while considered reasonable by the Company as of the date of this press release,
are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, level of activity,
performance or achievements or future events or developments to differ materially from those expressed or implied by the forward-looking
statements, including, without limitation: macroeconomic factors such as inflation and recessionary conditions, substantial doubt regarding
the Company’s ability to continue as a going concern due to recurring losses from operations; inability to increase cash flow and/or
raise sufficient capital to support the Company’s operating activities and fund its cash obligations, repay indebtedness and satisfy
the Company’s working capital needs and debt obligations; prolonged decline in the price of the Company’s common shares (the
“Common Shares”) reducing the Company’s ability to raise capital; inability to satisfy debt covenants under the
Credit Facility and the potential acceleration of indebtedness; risks related to the resolution of the Company’s ongoing litigation
with Benjamin Klein and compliance with the terms of their settlement agreement; risks related to the ability to continue to negotiate
amendments to the Credit Facility to prevent a default; risks relating to the Company’s ability to deliver and execute on the previously-announced
restructuring plan (the “Restructuring Plan”) and the possible failure to complete the Restructuring Plan on terms
acceptable to the Company or its suppliers (including Neuronetics, Inc.), or at all; risks relating to maintaining an active, liquid
and orderly trading market for Common Shares as a result of the Company’s recent delisting notification and potential inability
to regain compliance with the Nasdaq Stock Market’s listing rules; risks relating to the Company’s ability to realize expected
cost-savings and other anticipated benefits from the Restructuring Plan; risks related to the Company’s negative cash flows, liquidity
and its ability to secure additional financing; increases in indebtedness levels causing a reduction in financial flexibility; inability
to achieve or sustain profitability in the future; inability to secure additional financing to fund losses from operations and satisfy
the Company’s debt obligations; risks relating to strategic alternatives, including restructuring or refinancing of the Company’s
debt, seeking additional debt or equity capital, reducing or delaying the Company’s business activities and strategic initiatives,
or selling assets, other strategic transactions and/or other measures, including obtaining bankruptcy protection, and the terms, value
and timing of any transaction resulting from that process; claims made by or against the Company, which may be resolved unfavorably to
us; risks relating to the Company’s dependence on Neuronetics, Inc. as its exclusive supplier of TMS devices. Additional risks
and uncertainties are discussed in the Company’s materials filed with the Canadian securities regulatory authorities and the United
States Securities and Exchange Commission from time to time, available at www.sedarplus.ca and www.sec.gov, respectively. These factors
are not intended to represent a complete list of the factors that could affect the Company; however, these factors should be considered
carefully. There can be no assurance that such estimates and assumptions will prove to be correct. The forward-looking statements contained
in this press release are made as of the date of this press release, and the Company expressly disclaims any obligation to update or alter
statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information,
future events or otherwise, except as required by law.
v3.24.0.1
X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
+ Details
Name: |
dei_AmendmentFlag |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
+ Details
Name: |
dei_DocumentPeriodEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:dateItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
+ Details
Name: |
dei_DocumentType |
Namespace Prefix: |
dei_ |
Data Type: |
dei:submissionTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
+ References
+ Details
Name: |
dei_EntityAddressAddressLine1 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition
+ References
+ Details
Name: |
dei_EntityAddressCityOrTown |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionISO 3166-1 alpha-2 country code.
+ References
+ Details
Name: |
dei_EntityAddressCountry |
Namespace Prefix: |
dei_ |
Data Type: |
dei:countryCodeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCode for the postal or zip code
+ References
+ Details
Name: |
dei_EntityAddressPostalZipCode |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityCentralIndexKey |
Namespace Prefix: |
dei_ |
Data Type: |
dei:centralIndexKeyItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate if registrant meets the emerging growth company criteria.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityEmergingGrowthCompany |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
+ Details
Name: |
dei_EntityFileNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:fileNumberItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
+ References
+ Details
Name: |
dei_EntityIncorporationStateCountryCode |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarStateCountryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityRegistrantName |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityTaxIdentificationNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:employerIdItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLocal phone number for entity.
+ References
+ Details
Name: |
dei_LocalPhoneNumber |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 13e -Subsection 4c
+ Details
Name: |
dei_PreCommencementIssuerTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 14d -Subsection 2b
+ Details
Name: |
dei_PreCommencementTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTitle of a 12(b) registered security.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b
+ Details
Name: |
dei_Security12bTitle |
Namespace Prefix: |
dei_ |
Data Type: |
dei:securityTitleItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the Exchange on which a security is registered.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection d1-1
+ Details
Name: |
dei_SecurityExchangeName |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarExchangeCodeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Section 14a -Number 240 -Subsection 12
+ Details
Name: |
dei_SolicitingMaterial |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTrading symbol of an instrument as listed on an exchange.
+ References
+ Details
Name: |
dei_TradingSymbol |
Namespace Prefix: |
dei_ |
Data Type: |
dei:tradingSymbolItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 -Section 425
+ Details
Name: |
dei_WrittenCommunications |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
Greenbrook TMS (NASDAQ:GBNH)
Historical Stock Chart
From Oct 2024 to Nov 2024
Greenbrook TMS (NASDAQ:GBNH)
Historical Stock Chart
From Nov 2023 to Nov 2024